Third Rock Ventures invests in transformational life science companies that show high growth potential
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 21, 2021
Ambys Medicines
|
Series A | $47M | Biotechnology | Yes |
Aug 8, 2018
Ambys Medicines
|
Series A | $60M | Biotechnology | Yes |
Nov 12, 2014
Blueprint Medicines
|
Series C | $50M | Bioinformatics | — |
Apr 23, 2014
Kala Pharmaceuticals
|
Series B | $22.50M | Biotechnology | — |
Jan 7, 2014
Blueprint Medicines
|
Series B | $25M | Bioinformatics | — |